Sutro Biopharma (STRO) PT Lowered to $20 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $9.10 --0%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Sutro Biopharma (NASDAQ: STRO) to $20.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- Kia Motors (000270:KS) (KIMTF) PT Lowered to KRW150,000 at Nomura/Instinet
- Haier Smart Home Co Ltd (600690:CH) PT Raised to RMB32.40 at Nomura/Instinet
- First Industrial Realty Trust (FR) PT Lowered to $60 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
